Pei-Lung Chen,
Associate Professor and Attending Physician,
National Taiwan University Hospital
As a geneticist and an endocrine doctor, Dr. Pei-Lung Chen has been focusing on identifying variants/genes responsible for various human diseases, including clinical genetic diagnosis for patients, as well as novel causative gene(s) identification for diseases. Dr. Chen received his M.D. degree from National Taiwan University (NTU), and his Ph.D. degree from the Human Genetics Program at Johns Hopkins University. Dr. Chen is currently an Associate Professor at Graduate Institute of Medical Genomics and Proteomics at NTU, and also an attending physician at Lab of Molecular Genetic Diagnostics, Department of Medical Genetics at NTU Hospital. Dr. Chen is a multidisciplinary expert applying NGS, Human Leukocyte Antigen (HLA) genotyping, model organisms, immune-sequencing and bioinformatics for precision medicine and biomedical research.
Next-Generation Sequencing (NGS) for Mendelian Disease Diagnosis, Precision Medicine and Novel Disease-Causing Gene Discovery
Thursday, 30 November 2017 at 14:30
Add to Calendar ▼2017-11-30 14:30:002017-11-30 15:30:00Europe/LondonNext-Generation Sequencing (NGS) for Mendelian Disease Diagnosis, Precision Medicine and Novel Disease-Causing Gene DiscoveryNext Generation Sequencing in the Clinic Asia Summit 2017 in Taipei, TaiwanTaipei, TaiwanSELECTBIOenquiries@selectbiosciences.com
NGS has become much more affordable, which allows clinical applications of genome-scale data. In the near future, NGS, especially whole genome sequencing (WGS), will greatly reshape our view and practice of precision medicine. In this presentation, Dr. Pei-Lung Chen will share his experience in applying NGS to genomic medicine and clinical genetic testing at National Taiwan University Hospital during the latest years. Dr. Chen will start from panel-based NGS diagnosis, and end with WGS-based diagnosis. It is now clear that sequencing is only one perspective of a more complex story. Advanced genomics analysis, including standard bioinformatics pipeline and possible artificial intelligence (AI)-assisted approaches, promises better outcome of clinical applications as well as precision medicine.
Add to Calendar ▼2017-11-30 00:00:002017-11-30 00:00:00Europe/LondonNext Generation Sequencing in the Clinic Asia Summit 2017Next Generation Sequencing in the Clinic Asia Summit 2017 in Taipei, TaiwanTaipei, TaiwanSELECTBIOenquiries@selectbiosciences.com